Fundraising FoxConnecticut Innovations — 2018 Investments
11 investments dated 2018 · listed companies and verified rows first · show all
Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.
BiotechHealthtechNew Haven, US
Stephen Uden(Founder)inMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)
Co-investors5AM VenturesCanaan PartnersF-Prime CapitalMitsui Global InvestmentPivotal Life SciencesSolasta Ventures+2 more
AI-based ultrasound analysis technology using machine learning to deliver fast and accurate clinical indications.
Co-investorsAgate Medical Investments LPMindset VentureDEFTA PartnersIsrael Innovation AuthorityOutlier VenturesPhilips Ventures+2 more
Ellis Brooklyn makes and sells fragrances, including eau de parfum and other scent products, positioned as vegan and cruelty-free.
ConsumerDirect to ConsumerMiami, US
Bee-Shyuan Shapiro(Managing Member and CEO)
Co-investorsPoint King CapitalREDO Ventures
Stamford, US
Antony H. Lee(Chief Executive Officer)
Co-investorsLerer HippeauLightspeed Venture Partners
BiotechNew Haven, US
David Spiegel(Executive Officer, Director)Douglas Manion(Executive Officer)Roy Prieb(Executive Officer, Director)Declan Doogan(Director)Charles G. Drake(Director)
BoardJohn W. Childs(Director)
Landsdowne Labs develops button battery technology that deactivates batteries after accidental ingestion to address health risks.
Deep TechHealthtechMedical DevicesNew MaterialsStamford, US
Jeffrey Karp(Executive Officer, Promoter)inRobert Langer(Director, Promoter)Bryan Laulicht(Executive Officer, Promoter)inMelissa Fensterstock(Executive Officer, Director, Promoter)in
BoardDaniel Goldberg(Director)Patrick O'Neill(Director)
Co-investorsBoston Harbor AngelsHBS Angels of BostonMEDA AngelsTaihill Venture
OncoSynergy is a clinical-stage immuno-oncology company developing monoclonal antibody therapeutics, including a pan-CD29 antibody and a PD1-targeting antibody.
BiotechHealthtechStamford, US
Anne-Marie Carbonell(Founder, CEO & Chief Medical Officer)inW. Shawn Carbonell(Executive Officer, Director)inRobert Dunkle(Director)
BoardAllen Salmasi(Director)inHen Suh Park(Director)
reThought Flood is a flood insurance underwriting platform that lets insurance brokers quote and bind flood coverage, assessing each building individually along with the full policy portfolio for risk-based pricing.
FintechInsurTechSaaSBroomfield, US
Cory Isaacson(Chief Executive Officer)inJames Rice(Chief Sales Officer/Acting Chief Operations Officer)inNicholas Lamparelli(Chief Underwriting Officer)Joe Zuk(Director)Venky Ganesan(Director)in
BoardDavid G. Miles(Director)in
Co-investorsArcTern VenturesIA Capital GroupManchesterStory Group, LLCPrototype CapitalStreamlined VenturesTitanium Ventures+1 more
Shelf provides an agentic AI platform for enterprises that builds an "AI Data Model" of a business by unifying structured and unstructured data across systems, allowing AI agents to reason, act, and scale.
AI & Machine LearningData & InfrastructureEnterprise SoftwareBrooklyn, US
Atul Singh(Executive Officer, Director)Lauren Elizabeth Jung(Director)
Co-investorsContour Venture PartnersOutsiders
Wellinks provides virtual pulmonary care for patients with respiratory conditions such as COPD, offering at-home remote monitoring, virtual pulmonary rehabilitation, one-on-one clinical coaching, and nurse triage.
Digital HealthHealthtechWellness & FitnessNew Haven, US
Ellen Su(Executive Officer, Director)inLevi DeLuke(Executive Officer, Director)in
Co-investorsHighCape Capital
Cutting-edge cybersecurity platform for MSPs
Monroe, US
Greg Gage(President of Issuer)Najaf Raza(Chief Operating Officer of Issuer)
Co-investorsAsymmetric Capital PartnersGeneral CatalystOutsidersInnospark Ventures
.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.